Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 175 of 3499 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/19/03
End: 02/08/18
Due: 02/08/19
Phase: N/A
Priority: Normal
Start: 10/01/10
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 02/08/01
End: 01/12/08
Due: 01/12/09
Phase: N/A
Priority: Normal
Start: 08/22/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/96
End: 01/31/02
Due: 01/31/03
Phase: N/A
Priority: Normal
Start: 03/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/95
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/02
End: 04/30/06
Due: 04/30/07
Phase: N/A
Priority: Normal
Start: 03/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/12/10
End: 04/29/15
Due: 04/29/16
Phase: N/A
Priority: Normal
Start: 02/09/12
End: 11/12/20
Due: 11/12/21
Phase: N/A
Priority: Normal
Start: 05/18/18
End: 11/05/19
Due: 11/05/20
Phase: N/A
Priority: Normal
Start: 05/16/12
End: 01/17/19
Due: 01/17/20
Phase: N/A
Priority: Normal
Start: 05/29/12
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 05/31/95
End: -
Due: -
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
Phase: N/A
Priority: Normal
Start: 03/19/98
End: 09/02/20
Due: 09/02/21
Phase: N/A
Priority: Normal
Start: 08/20/18
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 10/26/20
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 05/22/23
End: 05/01/27
Due: 05/01/28
Phase: N/A
Priority: Normal
Start: 01/02/12
End: 06/28/17
Due: 06/28/18
Phase: N/A
Priority: Normal
Start: 02/04/21
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 02/15/22
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 01/31/11
Due: 01/31/12